Apuli Maricel
Transaction: 07/30/2026
SELL
Change
-2,000
Price
$80.06
Filing
08/03/2026
Type
SELL
BridgeBio Pharma, Inc.
BBIO • Biotechnology
$74.84
▼ -0.57 (-0.76%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$14.62B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 51.5%Healthy liquidity · 2.62Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:06 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$74.84
Change-0.76%
Shares Out195.29M
Market Cap$14.62B
Enterprise Value$13.93B
52W Range46.81 - 93.42
Beta0.98
P/E-20.99
P/S21.56
P/B-5.83
P/FCF-33.38
EV/Sales20.55
Price$74.84
Change-0.76%
Shares Out195.29M
Market Cap$14.62B
Enterprise Value$13.93B
52W Range46.81 - 93.42
Beta0.98
P/E-20.99
P/S21.56
P/B-5.83
P/FCF-33.38
EV/Sales20.55
EV/EBITDA-24.63
EV/FCF-31.82
Earnings Yield-4.76%
FCF Yield-3.00%
Dividend Yield0.00%
Gross Margin94.37%
Oper. Margin-113.35%
Profit Margin-145.26%
Debt/Eq-1.31
Current Ratio2.62
Quick Ratio2.52
Target$109.08
Target Upside45.75%
Target Median$108.50
Target Range97.00 - 130.00
Volume3.08M
Avg Volume3.09M
EPS Surprise-0.16
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 51.5%Healthy liquidity · 2.62Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 27 analyst votes · 2026-09-04
94/100
Bullish
Bullish
24
Hold
3
Bearish
0
Price Target
2026-08-12
Low
$83.00
Mean
$103.75
Median
$101.00
High
$130.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Cook Jennifer E.
Transaction: 07/09/2026
SELL
Change
-19,000
Price
$8.45
Filing
07/13/2026
Type
SELL
Cook Jennifer E.
Transaction: 07/09/2026
SELL
Change
-112,422
Price
$90.00
Filing
07/13/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Apuli Maricel | SELL | -2,000 | $80.06 | 07/30/2026 | 08/03/2026 |
| Cook Jennifer E. | SELL | -19,000 | $8.45 | 07/09/2026 | 07/13/2026 |
| Cook Jennifer E. | SELL | -112,422 | $90.00 | 07/09/2026 | 07/13/2026 |
| Ellis Andrea | SELL | -17,167 | $16.75 | 07/09/2026 | 07/13/2026 |
| Ellis Andrea | SELL | -17,167 | $84.00 | 07/09/2026 | 07/13/2026 |
| Cook Jennifer E. | SELL | -17,167 | $16.75 | 06/24/2026 | 06/24/2026 |
| Cook Jennifer E. | SELL | -37,167 | $70.00 | 06/24/2026 | 06/24/2026 |
| Valantine Hannah | SELL | -2,196 | $68.57 | 06/23/2026 | 06/24/2026 |
| Cook Jennifer E. | SELL | -2,196 | $68.57 | 06/23/2026 | 06/24/2026 |
| Satvat Ali J. | BUY | +5,277 | $68.92 | 06/22/2026 | 06/24/2026 |
| Satvat Ali J. | BUY | +3,990 | Not reported | 06/22/2026 | 06/24/2026 |
| Dachille Douglas A. | BUY | +5,277 | $68.92 | 06/22/2026 | 06/24/2026 |
| Dachille Douglas A. | BUY | +3,990 | Not reported | 06/22/2026 | 06/24/2026 |
| MCCORMICK FRANK | BUY | +5,277 | $68.92 | 06/22/2026 | 06/24/2026 |
| MCCORMICK FRANK | BUY | +3,990 | Not reported | 06/22/2026 | 06/24/2026 |
| MOMTAZEE JAMES C | BUY | +5,277 | $68.92 | 06/22/2026 | 06/24/2026 |
| MOMTAZEE JAMES C | BUY | +3,990 | Not reported | 06/22/2026 | 06/24/2026 |
| Hassan Fred | BUY | +5,277 | $68.92 | 06/22/2026 | 06/24/2026 |
| Hassan Fred | BUY | +3,990 | Not reported | 06/22/2026 | 06/24/2026 |
| Ellis Andrea | BUY | +5,277 | $68.92 | 06/22/2026 | 06/24/2026 |